PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
May 2, 2013 | ISSUE NUMBER 298 VOL 10

Healthcare Reform
Will Congress Provide Sequester “Flexibility” for User Fees?
In addition to FDA contending with the 7.8% reduction in funding for its appropriated funds,the OMB has determined that the budget reduction policy applies to user fees paid by manufacturers to support specific FDA approval and oversight functions. FDA thus is collecting all its authorized fees — but is unable to touch a good chunk of the money ...Read more

Cegedim Relationship Management
2013 Trends in Aggregate Spend and Disclosure Compliance - Complimentary Report
Cegedim Relationship Management's annual report discovers 89% will utilize an automated reporting solution for Sunshine Act compliance;   nearly 60% plan to use a third-party solution.  The report provides a comprehensive overview of how increased transparency is affecting US pharmaceutical and medical device industries. To read more, download the complimentary report today

Healthcare Reform
A Global Consensus: Oncologists Spooked by Healthcare Reform
A new survey reveals that oncologists from the US, China, Brazil, and the EU Big 5 expressed strong dissatisfaction with the direction and pace of local healthcare initiatives ...Read More

CEO Compensation Data
Complete salary, bonus & market capitalization data in biotech.
www.bioworld.com

Patient Information
PCORI Launches Clinical Research Network to Support Trials, Outcomes Research
The new National Patient-Centered Clinical Research Network funded by the Patient-Centered Outcomes Research Institute (PCORI) aims to provide patients and clinicians with useful information on treatment options and outcomes. By encouraging more comparative clinical effectiveness research (CER), the program also has potential to support development of new drugs and devices
...Read more

Marketing
Forget Digital Differentiation: Focus on ‘Cross-Channel Fusion’
Companies are coming to realize that digital is not just about “differentiation” and “innovation” — the next stage is “fusion”, the integration of digital into the overall marketing mix
...Read more

eDirectory
Pharmaceutical Technology and BioPharm International Marketplace
Advanstar Communications’ new Pharmaceutical Technology and BioPharm International Marketplace is vibrant online community that brings pharmaceutical buyers and suppliers together with industry-leading thought leadership content from the publications, in-depth product information from suppliers and real-time social media features
...Read more

Marketing to Professionals
Pharm Exec’s What Physician’s Want Vol. I & II
How, when and why physicians consume information. Information on marketing, detailing, sampling, prescribing, CME, conventions and meetings from some of the best in the industry.  Best methods to communicate with docs.  New ideas from reorganization to alternative sales channels to embedded outsourcing
...Read more

// VentiRx Pharmaceuticals (San Diego, CA) appointed Dr James Kyle Bryan as Chief Medical Officer.//Dr Andrey Bazovoy has moved from Quintiles to clinical research organization Cromos (Portland, OR) where he takes the role of Director, Clinical Operations.//Online physician network alliance Networks in Health appointed Alex Merckx as International Development Manager.//

May 6–7: CBI’s 10th Forum on Patient Reported Outcomes
Philadelphia, PA.


May 21–22: Regulatory Submission and Reporting Strategies
Washington, DC.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin


Survey
Has your department been downsized? If yes, by how much?

Click To Vote
Quick Links

Budget Cutters Propose Big Hits on Pharma

On-Market Pricing Strategies

Tough Times Ahead for New Medicines under NHS England